INSTAGE: A Randomized Trial of Nintedanib Plus Sildenafil Versus Nintedanib Alone in Patients with Idiopathic Pulmonary Fibrosis (IPF) and Advanced Lung Function Impairment

被引：0
|
作者：
Kolb, M. R. [1 ]
Wells, A. [2 ,3 ]
Behr, J. [4 ,5 ]
Richeldi, L. [6 ]
Schnaidt, S. [7 ]
Quaresma, M. [7 ,8 ]
Stowasser, S. [7 ]
Raghu, G. [9 ]
Martinez, F. J. [10 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Imperial Coll, Natl Inst Hlth Res Resp Biomed Res Unit, Royal Brompton & Harefield NHS Fdn Trust, London, England
[3] Imperial Coll, Natl Heart & Lung Inst, London, England
[4] Univ Munich LMU, Med Klin & Poliklin 5, Munich, Germany
[5] Asklepios Klin Munchen Gauting, German Ctr Lung Res, Munich, Germany
[6] Univ Cattolica Sacro Cuore, Fdn Policlinico A Gemelli, Rome, Italy
[7] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[8] Heidelberg Univ, Thoraxklin, Ctr Interstitial & Rare Lung Dis, Pneumol & Resp Care Med, Heidelberg, Germany
[9] Univ Washington, Seattle, WA 98195 USA
[10] Weill Cornell Med Coll, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1645
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-life Data on the Safety and Tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) Patients: A Single-Centre Study
    Thong, L.
    Bowen, B.
    Henry, M. T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S28 - S29
  • [42] EFFECT OF DOSE REDUCTIONS AND/OR INTERRUPTIONS ON THE EFFICACY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): SUBGROUP ANALYSIS OF THE INPULSIS TRIALS
    Maher, T. M.
    Inoue, Y.
    Case, A. H.
    Sakamoto, W.
    Stowasser, S.
    Wuyts, W. A.
    THORAX, 2017, 72 : A253 - +
  • [43] No Effect of Dose Adjustments on Long-Term Reduction in FVC Decline With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (IPF)
    Huggins, John
    Meyer, Keith
    Stansen, Wibke
    Quaresma, Manuel
    Kreuter, Michael
    CHEST, 2017, 152 (04) : 452A - 452A
  • [44] Effect Of Dose Reductions And/or Interruptions On The Efficacy Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Subgroup Analysis Of The Inpulsis Trials
    Maher, T. M.
    Inoue, Y.
    Case, A. H.
    Sakamoto, W.
    Stowasser, S.
    Wuyts, W. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Improvement In Forced Vital Capacity (FVC) With Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From The Inpulsis Trials
    Flaherty, K. R.
    Kolb, M.
    Vancheri, C.
    Tang, W.
    Conoscenti, C. S.
    Richeldi, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [46] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin E.
    Zhong, Jun
    Papakonstantinou, Eleni
    Karakiulakis, George
    Tamm, Michael
    Seidel, Petra
    Sun, Qingzhu
    Mandal, Jyotshna
    Lardinois, Didier
    Lambers, Christopher
    Roth, Michael
    RESPIRATORY RESEARCH, 2014, 15
  • [47] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Katrin E Hostettler
    Jun Zhong
    Eleni Papakonstantinou
    George Karakiulakis
    Michael Tamm
    Petra Seidel
    Qingzhu Sun
    Jyotshna Mandal
    Didier Lardinois
    Christopher Lambers
    Michael Roth
    Respiratory Research, 15
  • [48] Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Bonovolias, Ioannis
    Tamm, Michael
    Lambers, Christopher
    Lardinois, Didier
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [49] Nintedanib: A Potent Inhibitor of Invadosome Formation by Lung Fibroblasts Derived from Patients with Idiopathic Pulmonary Fibrosis
    Lebel, M.
    Cliche, D.
    Charbonneau, M.
    Bilodeau, G.
    Cantin, A. M.
    Dubois, C. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [50] Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study
    Yin, Lorraine Thong Wan
    Bowen, Bernadette
    Henry, Micahel
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345